A topical fixed-dose combination gel/cream primarily indicated for the treatment of mild to moderate inflammatory acne vulgaris. It combines the antibacterial action of clindamycin, the anti-inflammatory and sebum-regulating properties of niacinamide, and the keratolytic and wound-healing effects of allantoin. This combination targets multiple pathogenic factors of acne: bacterial proliferation, inflammation, excess sebum, and abnormal follicular keratinization.
Adult: Apply a thin film to the affected area(s) twice daily, morning and evening, after cleansing and drying the skin.
Note: 1. Wash hands and affected area with a gentle cleanser. Pat dry. 2. Apply a pea-sized amount for the entire face (or proportionally for smaller areas). 3. Gently spread as a thin, even film. 4. Avoid eyes, lips, nostrils, mucous membranes, and broken skin. 5. May be used under non-comedogenic moisturizer/sunscreen if needed.
The combination exerts a multi-targeted effect on acne pathogenesis. Clindamycin inhibits protein synthesis in Cutibacterium acnes, reducing bacterial colonization and inflammatory mediators. Niacinamide exerts anti-inflammatory effects by inhibiting leukocyte chemotaxis and the release of pro-inflammatory cytokines (IL-1, TNF-α). It also reduces sebum production and improves skin barrier function. Allantoin promotes keratolysis (softening and shedding of the stratum corneum), unclogs pores, and stimulates epithelial cell proliferation and wound healing.
Pregnancy: Category B (US FDA). Clindamycin topical is considered low risk. Niacinamide and allantoin are not expected to pose a risk. However, use only if clearly needed and under medical supervision. Large-scale human studies are lacking.
Driving: No effect on driving ability.
| Erythromycin (topical or systemic) | Antagonism; both bind to the same ribosomal site, reducing clindamycin's antibacterial efficacy. | Major |
| Neuromuscular blocking agents (e.g., Pancuronium) | Clindamycin may enhance neuromuscular blockade. | Moderate (relevant only if significant systemic absorption) |
| Topical Retinoids (Tretinoin, Adapalene) | Increased risk of skin irritation, dryness, and peeling. Recommend staggered application (e.g., one in AM, one in PM). | Moderate |
| Topical Benzoyl Peroxide | Potential for mutual inactivation if applied simultaneously. Also increases irritation risk. Can be used at different times of day. | Moderate |
Same composition (Allantoin (0.5% w/w) + Clindamycin (1% w/w) + Niacinamide (4% w/w)), different brands: